breast cancers

Firm Says Test Judges Risk For Common Breast Cancers

admin — Wed, 08 Oct 2008 00:00:00 -0500

A biotech company today will begin offering the first genetic test to assess a woman's risk for the most common forms of breast cancer, reigniting debate about the growing number of unregulated genetic tests.

deCODE BreastCancer launches, genetic test screens for risk of m...

admin — Wed, 08 Oct 2008 00:00:00 -0500

(Porter Novelli) deCODE genetics has launched deCODE BreastCancer, a new tool for assessing risk of the common forms of breast cancer. For the first time, a woman concerned about breast cancer can speak with her physician about a genetic test to better understandher lifetime risk of developing the common forms of the disease, which result from the interplay of genetic as well as environmental and lifestyle factors and represent 95 percent of all breast cancers.

Don't Bet against Me!: Beating the Odds Against Breast Cancer and in Life

admin — Tue, 16 Sep 2008 03:34:01 -0500

Deanna Favre & Angela Elwell Hunt

Living as a football player's wife in the fishbowl of Green Bay Wisconsin can't be easy for someone like Deanna Favre. Self-described as very shy and uncomfortable in the spotlight, she has generally tried to live her life and do her humanitarian works...

Breast cancer vaccine helps body fight tumors

admin — Mon, 15 Sep 2008 13:55:00 -0500

A new experimental breast cancer vaccine could prove highly effective in treating 20 to 30 percent of breast cancers, according to researchers.

U-M study: Herceptin targets breast cancer stem cells

admin — Wed, 09 Jul 2008 00:00:00 -0500

(University of Michigan Health System) A gene that is overexpressed in 20 percent of breast cancers increases the number of cancer stem cells, the cells that fuel a tumor's growth and spread, according to a new study from the University of Michigan Comprehensive Cancer Center.

Lack of CHFR gene expression sets stage for breast cancer

admin — Thu, 19 Jun 2008 00:00:00 -0500

(University of Michigan Health System) University of Michigan scientists have identified key steps in breast-tissue cell division that go awry when CHFR's action is low or absent. The gene's expression is missing in more than a third of breast cancers. The findings could make it possible to identify which patients are more likely to benefit from taxanes, a class of widely used cancer drugs which includes paclitaxel and docetaxel.

Team discovers new inhibitors of estrogen-dependent breast cance...

admin — Mon, 16 Jun 2008 00:00:00 -0500

(University of Illinois at Urbana-Champaign) Researchers have discovered a new family of agents that inhibit the growth of estrogen-dependent breast cancer cells. The finding, described today at a meeting of the Endocrine Society, has opened an avenue of research into new drugs to combat estrogen-dependent breast cancers.

Future hope for patients with breast cancers resistant to tamoxi...

admin — Mon, 16 Jun 2008 00:00:00 -0500

(The Endocrine Society) Researchers have found a new family of therapeutic agents that interferes with the ability of estrogen to stimulate the growth of breast cancer cells. The results of the new study will be presented by Nicole Patterson at the Endocrine Society's 90th Annual Meeting in San Francisco.

Adding ultrasound screening to mammography brings benefits, risk...

admin — Tue, 13 May 2008 00:00:00 -0500

(Brown University) Results from a major clinical trial show that adding a screening ultrasound examination to routine mammography reveals more breast cancers than mammography alone -- but also increases the rates of false positive findings. The American College of Radiology Imaging Net-work, whose biostatistics center is located at Brown University, conducted the study and reported the results in the Journal of the American Medical Association.

Previously unseen switch regulates breast cancer response to est...

admin — Thu, 08 May 2008 00:00:00 -0500

(Emory University) A tiny modification called methylation on estrogen receptors prolongs the life of these growth-driving molecules in breast cancer cells. Most breast cancers contain estrogen receptors, which enable them to grow in the presence of the hormone estrogen. Their presence can determine whether tumors will respond to the estrogen-blocking drug tamoxifen. The finding will help researchers sort out how mutations change the estrogen receptor's function and allow some breast cancers to resist tamoxifen.